Prescription Drug Sales Growth Expected To Slow In 2008, IMS Report Says
Main Category: Pharmacy / PharmacistAlso Included In: Regulatory Affairs / Drug Approvals
Article Date: 02 Nov 2007 - 9:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
Sales growth for prescription drugs in 2008 is expected to increase at the lowest rate in decades, according to an annual forecast released Thursday by health care information and consulting firm IMS Health, the Wall Street Journal reports. The report projects that U.S. sales of brand-name and generic prescription drugs in 2008 will experience growth rates between 4% and 5%, compared with rates between 5% and 6% this year.
The estimate puts U.S. sales at as much as $305 billion. Worldwide sales in 2008 are expected to increase to as much as $745 billion, a growth rate of 5% to 6%, which also is a deceleration from 2007 (Whalen, Wall Street Journal, 11/1). In addition, according to the report, the U.S. will see its worldwide market share for drugs decrease to one-third, compared with half of global market share two years ago, the AP/Washington Post reports.
IMS said the slowing sales growth in part is caused by increased FDA regulation and scrutiny of new drugs seeking approval. IMS predicts slower approvals and more warning labels in the future (Perrone, AP/Washington Post, 11/1). According to the Journal, another factor is brand-name drugs losing their hold on the market as patents expire and generic versions are approved. IMS estimates that generic drugs will fill two-thirds of U.S. prescriptions in 2008, compared with half in 2003 (Wall Street Journal, 11/1).
Murray Aitken, senior vice president at IMS, said, "What we see is more information on drug usage becoming available and being mined to find risks and safety issues," adding, "Overall, this means more uncertainty for companies, as well as for their ability to get products to patients" (AP/Washington Post, 11/1).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/87434.php>
APA
http://www.medicalnewstoday.com/releases/87434.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




